サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1493087

脳卒中管理の世界市場規模調査：タイプ別、用途別、地域別予測：2022～2032年

Global Stroke Management Market Size Study, by Type (Diagnostics, Therapeutics, Software), by Application (Ischemic Stroke, Haemorrhagic Stroke) and Regional Forecasts 2022-2032

出版日
ページ情報
英文 200 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.08円
脳卒中管理の世界市場規模調査：タイプ別、用途別、地域別予測：2022～2032年
出版日: 2024年06月10日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文 200 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の脳卒中管理市場は、2023年に約375億2,000万米ドルとなり、予測期間の2024年から2032年には7.40%以上の健全な成長率で成長すると予測されています。

脳卒中管理とは、脳への血流が突然途絶える脳卒中を経験した人に提供される包括的な治療とケアを指します。この血流障害は、血管の閉塞（虚血性脳卒中）または血管の破裂（出血性脳卒中）によって引き起こされます。脳卒中の管理には、脳へのさらなる損傷を防ぎ、障害を最小限に抑え、回復を促すことを目的としたさまざまな医学的介入や治療が含まれます。これには、血栓溶解薬（血栓溶解剤）や血栓除去術などの緊急治療、理学療法、言語療法、作業療法などのリハビリテーション療法、将来の脳卒中を予防するための薬物療法、高血圧、糖尿病、喫煙などの危険因子を減らすための生活習慣の改善などが含まれます。脳卒中管理の目標は、脳卒中患者の転帰と生活の質を改善することです。世界の脳卒中治療市場は、遠隔脳卒中治療のための遠隔医療やデジタルヘルスソリューションの台頭、早期発見と個別化治療のための人工知能（AI）と機械学習（ML）の統合、連携と介入効果を向上させるための脳卒中集学的チームと包括的センターの重視など、注目すべき発展を遂げています。これらの進展は、脳卒中管理における技術革新、効率性、患者転帰の改善を強調するものです。

世界の脳卒中管理市場は、主にいくつかの重要な要因によって支えられています。主要な要因は、遠隔医療やデジタルヘルスソリューションなどの医療技術の進歩であり、これにより脳卒中患者の遠隔評価や治療が容易になり、専門医療へのアクセスが向上します。さらに、脳卒中治療における人工知能（AI）と機械学習（ML）アルゴリズムの統合が進むことで、早期発見と個別化された治療計画が強化され、患者管理の向上につながります。さらに、学際的な脳卒中チームや包括的な脳卒中センターが重視されることで、ヘルスケア専門家間の連携が向上し、タイムリーな介入が保証され、患者の転帰が改善されます。しかし、市場には一定の抑制要因もあります。これには、遠隔医療やデジタルヘルスソリューションを規制する枠組みに関する課題や、AI主導のヘルスケア技術におけるデータプライバシーやセキュリティに関する懸念が含まれます。さらに、先進的な脳卒中管理技術の導入に関連するコストや熟練した専門家の必要性が、世界の脳卒中管理市場におけるこれらの技術革新の普及と最適な活用の障壁となっています。

脳卒中管理の世界市場調査において考慮した主要な地域は、アジア太平洋、北米、欧州、中南米、その他ラテンアメリカ地域です。北米は脳卒中管理の世界市場において優位を占めている地域です。この地域は、先進的なヘルスケアインフラ、活発な研究開発活動、革新的な脳卒中管理技術の採用率が高いことが理由です。この地域は、患者数の多さ、ヘルスケア支出の増加、脳卒中の予防と治療に対する意識の高まりが促進力となっています。さらに、医療サービスへのアクセス改善を目的とした政府の取り組みや医療改革が、市場の成長をさらに後押ししています。ヘルスケアシステムの改善、意識の高まり、革新的な脳卒中管理手法の採用が増加しています。脳卒中治療における北米の優位性は、世界の脳卒中管理市場の成長と発展に大きな展望をもたらします。一方、アジア太平洋の市場は、予測期間中に最も速い速度で発展すると予想されます。

目次

第1章 世界の脳卒中管理市場の定義と調査の前提条件

  • 調査目的
  • 市場の定義
  • 調査の前提条件
    • 包含事項・除外事項
    • 制限事項
    • 供給サイド分析
      • 入手可能性
      • インフラ
      • 規制環境
      • 市場競争
      • 経済性（消費者の視点）
    • 需要サイド分析
      • 規制の枠組み
      • 技術の進歩
      • 環境への配慮
      • 消費者の意識と受容
  • 調査手法
  • 調査対象年
  • 通貨換算レート

第2章 エグゼクティブサマリー

  • 脳卒中管理の世界市場規模・予測（2022～2032年）
  • 地域別概要
  • セグメント別概要
    • タイプ別
    • 用途別
  • 主要動向
  • 景気後退の影響
  • アナリストの結論・提言

第3章 脳卒中管理の世界市場力学

  • 市場促進要因
  • 市場の課題
  • 市場機会

第4章 脳卒中管理の世界市場産業分析

  • ポーターのファイブフォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
    • ポーターのファイブフォースモデルへの未来的アプローチ
    • ポーターのファイブフォースの影響分析
  • PESTEL分析
    • 政治
    • 経済
    • 社会
    • 技術
    • 環境
    • 法律
  • 主要な投資機会
  • 主要な成功戦略
  • 破壊的動向
  • 業界専門家の視点
  • アナリストの結論・提言

第5章 脳卒中管理の世界市場規模・予測：タイプ別、2022～2032年

  • 診断薬
  • 治療薬
  • ソフトウェア

第6章 脳卒中管理の世界市場規模・予測：用途別、2022～2032年

  • 虚血性脳卒中
  • 出血性脳卒中

第7章 脳卒中管理の世界市場規模・予測：地域別、2022～2032年

  • 北米の脳卒中管理市場
    • 米国
      • タイプの内訳規模・予測、2022～2032年
      • 用途の内訳規模・予測、2022～2032年
    • カナダの脳卒中管理市場
  • 欧州の脳卒中管理市場
    • 英国の脳卒中管理市場
    • ドイツの脳卒中管理市場
    • フランス脳卒中管理市場
    • スペイン脳卒中管理市場
    • イタリアの脳卒中管理市場
    • その他欧州の脳卒中管理市場
  • アジア太平洋の脳卒中管理市場
    • 中国の脳卒中管理市場
    • インドの脳卒中管理市場
    • 日本の脳卒中管理市場
    • オーストラリアの脳卒中管理市場
    • 韓国の脳卒中管理市場
    • その他アジア太平洋の脳卒中管理市場
  • ラテンアメリカの脳卒中管理市場
    • ブラジルの脳卒中管理市場
    • メキシコの脳卒中管理市場
    • その他ラテンアメリカの脳卒中管理市場
  • 中東・アフリカの脳卒中管理市場
    • サウジアラビアの脳卒中管理市場
    • 南アフリカの脳卒中管理市場
    • その他中東・アフリカの脳卒中管理市場

第8章 競合情報

  • 主要企業のSWOT分析
  • 主要市場戦略
  • 企業プロファイル
    • Deepnoid Co., Ltd.
      • 主要情報
      • 概要
      • 財務（データの入手可能性によります）
      • 製品概要
      • 市場戦略
    • B. Braun SE
    • Aidoc Medical Ltd
    • NeuraSignal, Inc.
    • Boston Scientific Corporation
    • Qure.ai Technologies Private Limited
    • Brainomix Limited
    • iSchemaView, Inc.
    • Koninklijke Philips N.V
    • Siemens AG

第9章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • 検証
    • 出版
  • 調査属性
図表

LIST OF TABLES

  • TABLE 1. Global Stroke Management market, report scope
  • TABLE 2. Global Stroke Management market estimates & forecasts by Region 2022-2032 (USD Billion)
  • TABLE 3. Global Stroke Management market estimates & forecasts by Type 2022-2032 (USD Billion)
  • TABLE 4. Global Stroke Management market estimates & forecasts by Application 2022-2032 (USD Billion)
  • TABLE 5. Global Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 6. Global Stroke Management market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 7. Global Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 8. Global Stroke Management market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 9. Global Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 10. Global Stroke Management market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 11. Global Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 12. Global Stroke Management market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 13. Global Stroke Management market by segment, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 14. Global Stroke Management market by region, estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 15. U.S. Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 16. U.S. Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 17. U.S. Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 18. Canada Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 19. Canada Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 20. Canada Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 21. UK Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 22. UK Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 23. UK Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 24. Germany Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 25. Germany Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 26. Germany Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 27. France Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 28. France Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 29. France Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 30. Italy Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 31. Italy Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 32. Italy Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 33. Spain Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 34. Spain Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 35. Spain Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 36. RoE Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 37. RoE Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 38. RoE Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 39. China Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 40. China Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 41. China Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 42. India Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 43. India Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 44. India Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 45. Japan Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 46. Japan Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 47. Japan Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 48. Australia Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 49. Australia Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 50. Australia Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 51. South Korea Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 52. South Korea Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 53. South Korea Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 54.
  • TABLE 55. RoAPAC Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 56. RoAPAC Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 57. RoAPAC Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 58. Brazil Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 59. Brazil Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 60. Brazil Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 61. Mexico Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 62. Mexico Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 63. Mexico Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 64. RoLA Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 65. RoLA Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 66. RoLA Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 67. Saudi Arabia Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 68. Saudi Arabia Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 69. Saudi Arabia Stroke Management market estimates & forecasts, 2022-2032 (USD Billion)
  • TABLE 70. South Africa Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 71.
  • TABLE 72. South Africa Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 73. South Africa Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 74. RoMEA Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 75. RoMEA Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 76. RoMEA Stroke Management market estimates & forecasts by segment 2022-2032 (USD Billion)
  • TABLE 77. List of secondary sources, used in the study of Global Stroke Management Market.
  • TABLE 78. List of primary sources, used in the study of Global Stroke Management Market.
  • TABLE 79. Years considered for the study.
  • TABLE 80. Exchange rates considered

LIST OF FIGURES

  • FIG 1. Global Stroke Management market, research methodology
  • FIG 2. Global Stroke Management market, market estimation techniques
  • FIG 3. Global market size estimates & forecast methods.
  • FIG 4. Global Stroke Management market, key trends 2023
  • FIG 5. Global Stroke Management market, growth prospects 2022-2032
  • FIG 6. Global Stroke Management market, porters 5 force model
  • FIG 7. Global Stroke Management market, pestel analysis
  • FIG 8. Global Stroke Management market, value chain analysis
  • FIG 9. Global Stroke Management market by segment, 2022 & 2032 (USD Billion)
  • FIG 10. Global Stroke Management market by segment, 2022 & 2032 (USD Billion)
  • FIG 11. Global Stroke Management market by segment, 2022 & 2032 (USD Billion)
  • FIG 12. Global Stroke Management market by segment, 2022 & 2032 (USD Billion)
  • FIG 13. Global Stroke Management market by segment, 2022 & 2032 (USD Billion)
  • FIG 14. Global Stroke Management market, regional snapshot 2022 & 2032
  • FIG 15. North America Stroke Management market 2022 & 2032 (USD Billion)
  • FIG 16. Europe Stroke Management market 2022 & 2032 (USD Billion)
  • FIG 17. Asia pacific Stroke Management market 2022 & 2032 (USD Billion)
  • FIG 18. Latin America Stroke Management market 2022 & 2032 (USD Billion)
  • FIG 19. Middle East & Africa Stroke Management market 2022 & 2032 (USD Billion)
  • FIG 20. Global Stroke Management market, company market share analysis (2023)
目次

Global Stroke Management Market is valued at approximately USD 37.52 billion in 2023 and is anticipated to grow with a healthy growth rate of more than 7.40% over the forecast period 2024-2032. Stroke management refers to the comprehensive care and treatment provided to individuals who have experienced a stroke, a sudden interruption of blood flow to the brain. This interruption can be caused by a blockage in a blood vessel (ischemic stroke) or by the rupture of a blood vessel (hemorrhagic stroke). Stroke management involves a range of medical interventions and therapies aimed at preventing further damage to the brain, minimizing disability, and facilitating recovery. This may include emergency treatments such as clot-dissolving medications (thrombolytics) or procedures to remove clots, rehabilitation therapies such as physical therapy, speech therapy, and occupational therapy, medications to prevent future strokes, and lifestyle modifications to reduce risk factors such as high blood pressure, diabetes, and smoking. The goal of stroke management is to improve outcomes and quality of life for stroke survivors. The Global Stroke Management market is experiencing notable developments such as the rise of telemedicine and digital health solutions for remote stroke care, the integration of artificial intelligence (AI) and machine learning (ML) for early detection and personalised treatment and emphasising multidisciplinary stroke teams and comprehensive centres to improve coordination and intervention effectiveness. These developments highlight innovation, efficiency, and improved patient outcomes in stroke management.

Several crucial factors primarily propel the Global Stroke Management market. A key factor is advancements in medical technology, including telemedicine and digital health solutions, which facilitate remote evaluation and treatment of stroke patients, improving access to specialized care. Additionally, increased integration of artificial intelligence (AI) and machine learning (ML) algorithms in stroke care enhances early detection and personalized treatment plans, leading to better patient management. Moreover, the emphasis on multidisciplinary stroke teams and comprehensive stroke centres improves coordination among healthcare professionals, ensuring timely interventions and enhancing patient outcomes. However, the market also faces certain restraints. These include challenges related to regulatory frameworks governing telemedicine and digital health solutions and concerns about data privacy and security in AI-driven healthcare technologies. Additionally, the cost associated with implementing advanced stroke management technologies and the need for skilled professionals pose barriers to widespread adoption and optimal utilization of these innovations in the Global Stroke Management market.

The key regions considered for the global Stroke Management market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is a dominating region in the Global Stroke Management Market. The region due to its advanced healthcare infrastructure, robust research and development activities, and high adoption rates of innovative stroke management technologies. The region is driven by a large patient pool, increasing healthcare spending, and rising awareness about stroke prevention and treatment. Moreover, government initiatives and healthcare reforms aimed at improving access to healthcare services are further fueling market growth. With improving healthcare systems, rising awareness, and increasing adoption of innovative stroke management practices. North America's dominance in stroke care, offers substantial prospects for growth and advancement in the Global Stroke Management Market. The market in Asia Pacific, on the other hand, is expected to develop at the fastest rate over the forecast period.

Major market player included in this report are:

  • Deepnoid Co., Ltd.
  • B. Braun SE
  • Aidoc Medical Ltd
  • NeuraSignal, Inc.
  • Boston Scientific Corporation
  • Qure.ai Technologies Private Limited
  • Brainomix Limited
  • iSchemaView, Inc.
  • Koninklijke Philips N.V
  • Siemens AG

The detailed segments and sub-segment of the market are explained below:

By Type

  • Diagnostics
  • Therapeutics
  • Software

By Application

  • Ischemic Stroke
  • Haemorrhagic Stroke

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Middle East & Africa
  • Saudi Arabia
  • South Africa
  • RoMEA

Years considered for the study are as follows:

  • Historical year - 2022
  • Base year - 2023
  • Forecast period - 2024 to 2032

Key Takeaways:

  • Market Estimates & Forecast for 10 years from 2022 to 2032.
  • Annualized revenues and regional level analysis for each market segment.
  • Detailed analysis of geographical landscape with Country level analysis of major regions.
  • Competitive landscape with information on major players in the market.
  • Analysis of key business strategies and recommendations on future market approach.
  • Analysis of competitive structure of the market.
  • Demand side and supply side analysis of the market

Table of Contents

Chapter 1. Global Stroke Management Market Definition and Research Assumptions

  • 1.1. Research Objective
  • 1.2. Market Definition
  • 1.3. Research Assumptions
    • 1.3.1. Inclusion & Exclusion
    • 1.3.2. Limitations
    • 1.3.3. Supply Side Analysis
      • 1.3.3.1. Availability
      • 1.3.3.2. Infrastructure
      • 1.3.3.3. Regulatory Environment
      • 1.3.3.4. Market Competition
      • 1.3.3.5. Economic Viability (Consumer's Perspective)
    • 1.3.4. Demand Side Analysis
      • 1.3.4.1. Regulatory frameworks
      • 1.3.4.2. Technological Advancements
      • 1.3.4.3. Environmental Considerations
      • 1.3.4.4. Consumer Awareness & Acceptance
  • 1.4. Estimation Methodology
  • 1.5. Years Considered for the Study
  • 1.6. Currency Conversion Rates

Chapter 2. Executive Summary

  • 2.1. Global Stroke Management Market Size & Forecast (2022- 2032)
  • 2.2. Regional Summary
  • 2.3. Segmental Summary
    • 2.3.1. By Type
    • 2.3.2. By Application
  • 2.4. Key Trends
  • 2.5. Recession Impact
  • 2.6. Analyst Recommendation & Conclusion

Chapter 3. Global Stroke Management Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Challenges
  • 3.3. Market Opportunities

Chapter 4. Global Stroke Management Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
    • 4.1.6. Futuristic Approach to Porter's 5 Force Model
    • 4.1.7. Porter's 5 Force Impact Analysis
  • 4.2. PESTEL Analysis
    • 4.2.1. Political
    • 4.2.2. Economical
    • 4.2.3. Social
    • 4.2.4. Technological
    • 4.2.5. Environmental
    • 4.2.6. Legal
  • 4.3. Top investment opportunity
  • 4.4. Top winning strategies
  • 4.5. Disruptive Trends
  • 4.6. Industry Expert Perspective
  • 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global Stroke Management Market Size & Forecasts by Type 2022-2032

  • 5.1. Diagnostics
  • 5.2. Therapeutics
  • 5.3. Software

Chapter 6. Global Stroke Management Market Size & Forecasts by Application 2022-2032

  • 6.1. Ischemic Stroke
  • 6.2. Haemorrhagic Stroke

Chapter 7. Global Stroke Management Market Size & Forecasts by Region 2022-2032

  • 7.1. North America Stroke Management Market
    • 7.1.1. U.S. Stroke Management Market
      • 7.1.1.1. Type breakdown size & forecasts, 2022-2032
      • 7.1.1.2. Application breakdown size & forecasts, 2022-2032
    • 7.1.2. Canada Stroke Management Market
  • 7.2. Europe Stroke Management Market
    • 7.2.1. U.K. Stroke Management Market
    • 7.2.2. Germany Stroke Management Market
    • 7.2.3. France Stroke Management Market
    • 7.2.4. Spain Stroke Management Market
    • 7.2.5. Italy Stroke Management Market
    • 7.2.6. Rest of Europe Stroke Management Market
  • 7.3. Asia-Pacific Stroke Management Market
    • 7.3.1. China Stroke Management Market
    • 7.3.2. India Stroke Management Market
    • 7.3.3. Japan Stroke Management Market
    • 7.3.4. Australia Stroke Management Market
    • 7.3.5. South Korea Stroke Management Market
    • 7.3.6. Rest of Asia Pacific Stroke Management Market
  • 7.4. Latin America Stroke Management Market
    • 7.4.1. Brazil Stroke Management Market
    • 7.4.2. Mexico Stroke Management Market
    • 7.4.3. Rest of Latin America Stroke Management Market
  • 7.5. Middle East & Africa Stroke Management Market
    • 7.5.1. Saudi Arabia Stroke Management Market
    • 7.5.2. South Africa Stroke Management Market
    • 7.5.3. Rest of Middle East & Africa Stroke Management Market

Chapter 8. Competitive Intelligence

  • 8.1. Key Company SWOT Analysis
  • 8.2. Top Market Strategies
  • 8.3. Company Profiles
    • 8.3.1. Deepnoid Co., Ltd.
      • 8.3.1.1. Key Information
      • 8.3.1.2. Overview
      • 8.3.1.3. Financial (Subject to Data Availability)
      • 8.3.1.4. Product Summary
      • 8.3.1.5. Market Strategies
    • 8.3.2. B. Braun SE
    • 8.3.3. Aidoc Medical Ltd
    • 8.3.4. NeuraSignal, Inc.
    • 8.3.5. Boston Scientific Corporation
    • 8.3.6. Qure.ai Technologies Private Limited
    • 8.3.7. Brainomix Limited
    • 8.3.8. iSchemaView, Inc.
    • 8.3.9. Koninklijke Philips N.V
    • 8.3.10. Siemens AG

Chapter 9. Research Process

  • 9.1. Research Process
    • 9.1.1. Data Mining
    • 9.1.2. Analysis
    • 9.1.3. Market Estimation
    • 9.1.4. Validation
    • 9.1.5. Publishing
  • 9.2. Research Attributes